Rheumatoid arthritis and interstitial lung disease: the role of comorbidities. Retrospective analysis of two RA inception cohorts in the UK

Rheumatoid Arthritis

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicenter cohort of 526 patients

Rheumatology (Oxford)

Serrano-Combarro A, Atienza-Mateo B, Martín-Gutierrez A, Ibarrola Paino L, Casafont-Solé I, Loarce-Martos J, Blanco-Madrigal JM, Ortega-Castro R, Mena-Vázquez N, Fernández-Díaz C, Loricera J, Ferrer D, Castañeda S, Blanco R, Spanish Collaborative Group of Interstitial Lung Disease Associated with Rheumatoid Arthritis

doi: 10.1093/rheumatology/keag023

Rheumatoid Arthritis

Incidence rates of interstitial lung disease events among patients with rheumatoid arthritis treated with abatacept or placebo, with background methotrexate: a post hoc pooled analysis from a compendium of clinical trials

Semin Arthritis Rheum

Dieudé P, Sparks JA, Fischer A, Chen L, Lozenski K, Dahan S, Chaballa M, Little W

doi: 10.1016/j.semarthrit.2025.152795

Rheumatoid Arthritis

The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis

Arthritis Res Ther

Zheng S, Zhou Z, Du G, Chen Q, Chen S, Lin J, Hu S, Zhang W, Zheng K, Zhuang J, Huang M, Ruaro B, Bruni C, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE, Wang Y

doi: 10.1186/s13075-025-03626-4

Rheumatoid Arthritis

Rheumatoid arthritis-associated interstitial lung disease in countries across the world

Semin Arthritis Rheum

Heckert SL, Maarseveen TD, Marges ER, Chopra A, Vega-Morales D, Toit RD, Winchow LL, Govind N, Toro-Gutiérrez CE, Knevel R, van der Helm-van Mil AH, Huizinga TW, Allaart CF, Bergstra SA

doi: 10.1016/j.semarthrit.2025.152719

Rheumatoid Arthritis

Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis

Rheumatology (Oxford)

Zhang Q, Qi Y, Wang X, McDermott GC, Chang SH, Chaballa M, Khaychuk V, Paudel ML, Sparks JA

doi: 10.1093/rheumatology/keaf380

Rheumatoid Arthritis

Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysis

J Autoimmun

Hässler S, Aste J, Berenbaum F, Rosenzwajg M, Sellam J, Klatzmann D, Maravic M

doi: 10.1016/j.jaut.2025.103502

Rheumatoid Arthritis

Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohorts

Ann Rheum Dis

Derksen VFAM, Lindschou J, Winkel P, Delgado GE, de Moel EC, Huizinga TWJ, März W, Jakobsen JC, van der Helm-Van Mil AHM, Toes REM, Ajeganova S, Gluud C, Leipe J, van der Woude D, CLARICOR Trial Group and the LURIC Study Group

doi: 10.1016/j.ard.2025.11.023

Systemic Sclerosis

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

Arthritis Res Ther

Hiura R, Ayano M, Uchino A, Hiura J, Ueda N, Tanaka A, Yoshizawa S, Kawano S, Sagawa F, Ota SI, Hirata A, Fujimoto S, Nishimura N, Takaki-Kuwahara A, Kimoto Y, Akashi K, Niiro H

doi: 10.1186/s13075-025-03654-0

Rheumatoid Arthritis

The impact of area-level socioeconomic status on disease outcomes in rheumatoid arthritis: results from an Australian longitudinal inception cohort study

J Rheumatol

Russell O, Lester S, Stanhope J, Griggs K, McWilliams L, Lee A, Proudman S, Black RJ, Hill CL

doi: 10.3899/jrheum.2025-0869

Related content

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicenter cohort of 526 patients

Incidence rates of interstitial lung disease events among patients with rheumatoid arthritis treated with abatacept or placebo, with background methotrexate: a post hoc pooled analysis from a compendium of clinical trials

The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis

Rheumatoid arthritis-associated interstitial lung disease in countries across the world

Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis

Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysis

Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohorts

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

The impact of area-level socioeconomic status on disease outcomes in rheumatoid arthritis: results from an Australian longitudinal inception cohort study